Scientific Advisory Board

Professor Lennart Lundberg,  co-founder and major shareholder

Prof. PhD. Lundberg has over 30 years in the pharmaceutical and biotech industry. His most recent position was within the management team of AnaMar AB as VP of Intellectual Property. Before that prof. Lundberg was at AstraZeneca AB (20 years), where his latest positions were as a Business Development Manager as well as being responsible for biotech patents at the cardiovascular and gastrointestinal business units. Prof. Lundberg has 75 papers published in the fields of biochemistry, biotechnology and gene technology connected to his expertise in protein engineering. He is also an inventor of several biotech patents.

Professor Rikard Holmdahl, Karolinska Institutet, Stockholm

Prof. Rikard Holmdahl MD, PhD. is currently holding a position as Head of division of Medical Inflammation Research at the Department of Medical Biochemistry and Biophysics (MBB) at Karolinska Institutet. His research is focused on inflammatory diseases, using models for arthritis as a prototype disease. He is a worldwide known expert within his field of science and he has received numerous prestigious awards for his work.

Dr. Björn Löwenadler, CEO of Adjuvare AB

Dr Löwenadler has a PhD in molecular immunology from Karolinska Institute. Löwenadler has extensive experience in preclinical and early clinical development projects and external collaborations. He has been a Director of Molecular Biology at Pharmacia, Head of Discovery Research Biovitrum, CSO within Arexis AB and Director in Discovery Sciences and External Collaborations at AstraZeneca R&D. Currently Löwenadler works as a consultant.

Management team: Dr Einar Pontén

Professor Solbritt Rantapää Dahlqvist, Umeå University

Solbritt Rantapää Dahlqvist, MD, PhD, Professor, senior at Department of Public Health and Clinical Medicine at Umeå University. She has been specialised on rheumatology for more than 30 years. Solbritt has published more than 200 peer reviewed scientific papers and trained 17 PhD students. Solbritt has received the Nanna Svartz award as well as the Swedish Rheumatology and Whyetts Price, and the Royal Skytteanska Society price for her research.

Professor Anders Fasth, University of Gothenburg

Prof. Anders Fasth MD, PhD. is presently Senior professor of pediatric immunology at University of Gothenburg and senior consultant at Queen Silvia Children’s Hospital. He is also senior consultant at Div of Pediatrics, National Children’s Hospital, San José, Costa Rica. His research is focused on the epidemiology  of juvenile idiopathic arthritis and the etiology and treatment of primary immunodeficiency. He has more than 250 peer-reviewed publications and has been awarded with several prizes and honorary memberships for his work in Latin America.

About Lipum